We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,382
Increased
6,044
Reduced
2,041
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFBI
7151
DELISTED
Affinity Bancshares
AFBI
$61.6K ﹤0.01%
3,519
+3,060
+667% +$65.7K
FEBZ icon
7152
TrueShares Structured Outcome February ETF
FEBZ
$30.9M
$61.5K ﹤0.01%
+1,790
New +$64.1K
RVP icon
7153
Retractable Technologies
RVP
$20.1M
$61.5K ﹤0.01%
89,423
-17,352
-16% -$11.9K
NBCR
7154
Neuberger Core Equity ETF
NBCR
$869M
$61.5K ﹤0.01%
2,306
+1,677
+267% +$45.4K
TLTD icon
7155
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund
TLTD
$689M
$61.4K ﹤0.01%
892
-73
-8% -$5.22K
EWO icon
7156
iShares MSCI Austria ETF
EWO
$184M
$61.3K ﹤0.01%
2,924
+479
+20% +$10.3K
HELX icon
7157
Franklin Genomic Advancements ETF
HELX
$30.8M
$61.1K ﹤0.01%
2,117
+1,668
+371% +$51.2K
CDIO icon
7158
Cardio Diagnostics
CDIO
$5.09M
$61.1K ﹤0.01%
+2,220
New +$30.8K
ALTO icon
7159
Alto Ingredients
ALTO
$349M
$60.7K ﹤0.01%
38,922
+26,941
+225% +$42.2K
SRG
7160
Seritage Growth Properties
SRG
$136M
$60.7K ﹤0.01%
14,724
+2,974
+25% +$12.8K
ORIS
7161
DELISTED
Oriental Rise Holdings
ORIS
$60.5K ﹤0.01%
+494
New +$253K
VS icon
7162
Versus Systems
VS
$8.08M
$60.4K ﹤0.01%
27,435
+22,418
+447% +$41.5K
BCRX icon
7163
PUT
BioCryst Pharmaceuticals
BCRX
$2.4B
$60.2K ﹤0.01%
8,000
CING icon
7164
Cingulate
CING
$69.8M
$60.1K ﹤0.01%
12,196
-1,553
-11% -$6.8K
JUNW icon
7165
AllianzIM U.S. Equity Buffer20 Jun ETF
JUNW
$377M
$60K ﹤0.01%
1,999
+1,373
+219% +$41K
STFS
7166
Star Fashion Culture Holdings
STFS
$4.38M
$59.6K ﹤0.01%
+211
New +$41.3K
SRBK icon
7167
SR Bancorp
SRBK
$145M
$59.5K ﹤0.01%
4,999
+4,985
+35,607% +$56.6K
DSY
7168
Big Tree Cloud Holdings
DSY
$22M
$59.4K ﹤0.01%
+943
New +$66.7K
CZWI icon
7169
Citizens Community Bancorp
CZWI
$203M
$59.4K ﹤0.01%
3,644
+2,344
+180% +$35.7K
LCTD icon
7170
iShares World ex U.S. Carbon Transition Readiness Aware Active ETF
LCTD
$294M
$59.3K ﹤0.01%
1,363
-81
-6% -$3.72K
GNLX icon
7171
Genelux
GNLX
$118M
$59.2K ﹤0.01%
25,091
-14,998
-37% -$39.9K
NEPH icon
7172
Nephros
NEPH
$44M
$59.1K ﹤0.01%
40,208
+40,087
+33,130% +$61.1K
GRML
7173
Greenland Mines Ltd
GRML
$28.1M
$59.1K ﹤0.01%
121,775
+106,469
+696% +$49.2K
TAVIU
7174
Tavia Acquisition Corp Unit
TAVIU
$58.8K ﹤0.01%
+5,857
New +$58.6K
DEMZ icon
7175
The Advisors' Inner Circle Fund III Democratic Large Cap Core ETF
DEMZ
$67.8M
$58.8K ﹤0.01%
+1,636
New +$59.6K

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.